1. MEG3: a novel long noncoding potentially tumour-suppressing RNA in meningiomas

   • Vladimir Balik
   • Josef Srovnal
   • Marian Hajduch

   Topic Review 11 January 2013 Pages: 1 - 8

   

2. Radiation induced brain injury: assessment of white matter tracts in a pre-clinical animal model using diffusion tensor MR imaging

   • Silun Wang
   • Deqiang Qiu
   • Pek-Lan Khong

   Laboratory Investigation 20 January 2013 Pages: 9 - 15

   

3. ZFX regulates glioma cell proliferation and survival in vitro and in vivo

   • Zhichuan Zhu
   • Kui Li
   • Jing Zheng

   Laboratory Investigation 16 January 2013 Pages: 17 - 25

   

4. miRNA-mediated tumor specific delivery of TRAIL reduced glioma growth

   • Yongli Bo
   • Guocai Guo
   • Weicheng Yao

   Laboratory Investigation 22 January 2013 Pages: 27 - 37

   

5. Harmine hydrochloride inhibits Akt phosphorylation and depletes the pool of cancer stem-like cells of glioblastoma

   • Huailei Liu
   • Dayong Han
   • Shiguang Zhao

   Laboratory Investigation 08 February 2013 Pages: 39 - 48

   

6. EGF signalling and rapamycin-mediated mTOR inhibition in glioblastoma multiforme evaluated by phospho-specific flow cytometry

   • Isabelle Cornez
   • Mrinal Joel
   • Torunn Berge

   Laboratory Investigation 09 January 2013 Pages: 49 - 57

   

7. MicroRNA-107 inhibits glioma cell migration and invasion by modulating Notch2 expression

   • Lei Chen
   • Xiang-Rong Chen
   • Xiao-Dan Jiang

   Laboratory Investigation 09 January 2013 Pages: 59 - 66

   

8. H3.3 G34R mutations in pediatric primitive neuroectodermal tumors of central nervous system (CNS-PNET) and pediatric glioblastomas: possible diagnostic and therapeutic implications?

   • Marco Gessi
   • Gerrit H. Gielen
   • Torsten Pietsch

   Laboratory Investigation 26 January 2013 Pages: 67 - 72

   

9. Knockdown of RLIP76 expression by RNA interference inhibits invasion, induces cell cycle arrest, and increases chemosensitivity to the anticancer drug temozolomide in glioma cells

   • Qi Wang
   • Jun Qian
   • Yicheng Lu

   Laboratory Investigation 06 January 2013 Pages: 73 - 82

   

10. Temozolomide use in adult patients with gliosarcoma: an evolving clinical practice

    • Gary V. Walker
    • Mark R. Gilbert
    • Mary Frances McAleer

    Clinical Study 25 December 2012 Pages: 83 - 89

    

11. The incidence and significance of multiple lesions in glioblastoma

    • Reena P. Thomas
    • Linda W. Xu
    • Seema Nagpal

    Clinical Study 26 January 2013 Pages: 91 - 97

    

12. Disability, body image and sports/physical activity in adult survivors of childhood CNS tumors: population-based outcomes from a cohort study

    • Krister K. Boman
    • Lina Hörnquist
    • Göran Gustafsson

    Clinical Study 26 January 2013 Pages: 99 - 106

13. A very rare cancer in Down syndrome: medulloblastoma. Epidemiological data from 13 countries

    • Daniel Satgé
    • Charles A. Stiller
    • Christian Rickert

    Clinical Study 11 January 2013 Pages: 107 - 114

14. Delayed development of a rhabdomyosarcoma following radiation for a spinal cord glioma

    • Edmond Mazbani
    • Robin L. Jones
    • Marc C. Chamberlain

    Clinical Study 08 January 2013 Pages: 115 - 118

    

15. Erratum to: Delayed development of a rhabdomyosarcoma following radiation for a spinal cord glioma

    • Edmond Marzbani
    • Robin L. Jones
    • Marc C. Chamberlain

    Erratum 22 January 2013 Pages: 119 - 119

16. Tryptophan PET in pretreatment delineation of newly-diagnosed gliomas: MRI and histopathologic correlates

    • David O. Kamson
    • Csaba Juhász
    • Sandeep Mittal

    Clinical Study 09 January 2013 Pages: 121 - 132

    

17. Re-irradiation with and without bevacizumab as salvage therapy for recurrent or progressive high-grade gliomas

    • Thomas Hundsberger
    • Detlef Brügge
    • Ludwig Plasswilm

    Clinical Study 12 January 2013 Pages: 133 - 139